Showing results (51-60 of 993) with videos related to
Sort By:
Pageof 100
Neuropharmacology|April 17, 2020
New hopes for disease modification in Parkinson's DiseaseWerner Poewe, Klaus Seppi, Kathrin Marini, et al.Brain and Language|December 31, 2003
Linguistic and neuropsychological deficits in crossed conduction aphasia. Report of three casesLisa Bartha, Peter Mariën, Werner Poewe, et al.Journal of Parkinson'S Disease|February 27, 2023
Pharmacological Treatment of Tremor in Parkinson's Disease RevisitedWalter Pirker, Regina Katzenschlager, Mark Hallett, et al.Movement Disorders : Official Journal of the Movement Disorder Society|June 1, 2011
Milestones in Parkinson's disease therapeuticsOlivier Rascol, Andres Lozano, Matthew Stern, et al.Movement Disorders : Official Journal of the Movement Disorder Society|May 5, 2006
Minimal clinically important change on the unified Parkinson's disease rating scaleAnette Schrag, Cristina Sampaio, Nicholas Counsell, et al.Movement Disorders : Official Journal of the Movement Disorder Society|May 13, 2022
How Does Deep Brain Stimulation Change the Course of Parkinson's Disease?Philipp Mahlknecht, Thomas Foltynie, Patricia Limousin, et al.Movement Disorders : Official Journal of the Movement Disorder Society|February 3, 2017
Meta-analysis of dorsolateral nigral hyperintensity on magnetic resonance imaging as a marker for Parkinson's diseasePhilipp Mahlknecht, Florian Krismer, Werner Poewe, et al.Parkinsonism & Related Disorders|March 2, 2024
Longitudinal brain changes in Parkinson's disease with severe olfactory deficitKazuya Kawabata, Epifanio Bagarinao, Klaus Seppi, et al.Movement Disorders : Official Journal of the Movement Disorder Society|December 7, 2006
Auditory startle reaction in primary blepharospasmJörg Müller, Martina Rinnerthaler, Werner Poewe, et al.CNS Drugs|September 2, 2019
Apomorphine for Parkinson's Disease: Efficacy and Safety of Current and New FormulationsFederico Carbone, Atbin Djamshidian, Klaus Seppi, et al.Pageof 100